Semler Scientific Corp (SMLR) - Tanggungan jangka dawa

Simbol lan logo merek Semler (SMLR)

This price chart for Semler Scientific, Inc. (SMLR) illustrates the performance of a company expanding its network of active sales agents to deploy vascular analysis systems through an unlimited bonus structure. Meanwhile, long-term debt stands at 0.00. Financial risks stem from a narrow product portfolio and the potential revision of insurance reimbursements. Further instability is introduced by the company's bet on cryptocurrency assets, which has overshadowed its primary medical business profile.

SMLR (Semler Scientific Corp) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 31.01.2026
Produk seri Semler Scientific Inc

Semler Scientific, Inc. (SMLR) is developing a network of cloud IT solutions for the diagnosis of vascular pathologies in US clinics. Rising capital expenditures on infrastructure are reflected in the dynamics of long-term liabilities, which measure the total volume of loans with maturities exceeding one year. This metric determines the level of financial leverage and the business's resilience to interest rates. Analyzing the corporation's volume of long-term loans and borrowings allows for an assessment of the risk of balance sheet overload during expansion.